Precigen to Participate in the 2022 Wells Fargo Healthcare Conference
Precigen, a biopharmaceutical company focused on gene and cell therapies, announced that its President and CEO, Helen Sabzevari, will participate in a fireside chat at the 2022 Wells Fargo Healthcare Conference in Boston, Massachusetts. The event is scheduled for September 7, 2022, at 11:35 AM ET. Precigen aims to improve patient lives through innovative therapies targeting urgent diseases, including areas like immuno-oncology and autoimmune disorders. More details regarding the conference can be found on their official website.
- None.
- None.
GERMANTOWN, Md., Sept. 1, 2022 /PRNewswire/ -- Precigen, Inc. (NASDAQ: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that Helen Sabzevari, PhD, President and CEO of Precigen, will participate in a fireside chat at the 2022 Wells Fargo Healthcare Conference in Boston, Massachusetts on Wednesday, September 7, 2022 at 11:35 AM ET.
Event details can be found on Precigen's website in the Events & Presentations section at investors.precigen.com/events-presentations.
Precigen: Advancing Medicine with Precision™
Precigen (NASDAQ: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated therapies toward clinical proof-of-concept and commercialization. For more information about Precigen, visit www.precigen.com or follow us on Twitter @Precigen, LinkedIn or YouTube.
Cautionary Statement Regarding Forward-Looking Statements
Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon the Company's current expectations and projections about future events and generally relate to plans, objectives, and expectations for the development of the Company's business, including the timing and progress of preclinical studies, clinical trials, discovery programs and related milestones, the promise of the Company's portfolio of therapies, and in particular its CAR-T and AdenoVerse therapies. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties, including the possibility that the timeline for the Company's clinical trials might be impacted by the COVID-19 pandemic, and actual future results may be materially different from the plans, objectives and expectations expressed in this press release. The Company has no obligation to provide any updates to these forward-looking statements even if its expectations change. All forward-looking statements are expressly qualified in their entirety by this cautionary statement. For further information on potential risks and uncertainties, and other important factors, any of which could cause the Company's actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in the Company's most recent Annual Report on Form 10-K and subsequent reports filed with the Securities and Exchange Commission.
Investor Contact:
Steven M. Harasym
Vice President, Investor Relations
Tel: +1 (301) 556-9850
investors@precigen.com
Media Contacts:
Donelle M. Gregory
press@precigen.com
Glenn Silver
Lazar-FINN Partners
glenn.silver@finnpartners.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/precigen-to-participate-in-the-2022-wells-fargo-healthcare-conference-301615928.html
SOURCE Precigen, Inc.
FAQ
What is the date and time of Precigen's participation in the 2022 Wells Fargo Healthcare Conference?
Who will represent Precigen at the Wells Fargo Healthcare Conference?
Where is the 2022 Wells Fargo Healthcare Conference being held?
What is the focus of Precigen's business?
How can I find more details about Precigen's conference participation?
